Uploaded March 2025 | Updated November 2026, 3 days ago
In this episode, Eric Genevois-Marlin discusses how modeling and simulation are increasingly being used to test hypotheses that would traditionally have been addressed through clinical trials. He also highlights how some regulatory approvals are now incorporating model-based predictions, marking a shift in the approach to clinical data.
Don’t miss this episode with lessons from two decades in pharma. Available now on all podcasting platforms and YouTube!
In this episode, Eric Genevois-Marlin discusses how modeling and simulation are increasingly being used to test hypotheses that would traditionally have been addressed through clinical trials. He also highlights how some regulatory approvals are now incorporating model-based predictions, marking a shift in the approach to clinical data.
Don’t miss this episode with lessons from two decades in pharma. Available now on all podcasting platforms and YouTube!










